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The 5’-EIA control regions of adenovirus (Ad) types 2, 3 and 12 were cloned upstream from the cat gene. Each serotype 
was characterized by unique organization of the S-El A non-coding region. All three 5’-non-coding ElA regions were 
able to stimulate the cat gene transcription in HeLa cells. Hybrid plasmids between Ad2/Ad3 and Ad2/Ad12 revealed 
the same level of CAT activity as the native plasmids but the optimum activity of promoter was achieved only when 
its organization was not modified. These observations suggest that various nuclear factors take part in the activation 
process of each promoter. 
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1. INTRODUCTION 
Adenovirus (Ad) provides a useful model system 
to study the control of eukaryotic gene expression. 
In human cells infected with Ad2 or Ad5, a set of 
five early viral promoters (ElA, ElB, E3, E2A and 
E4) are coordinately expressed [l-3]. The ElA 
gene is one of the first transcription units to be ex- 
pressed. Then, after infection, the products of that 
gene are required to activate transcription of other 
early viral genes [l-3]. Primary ElA transcript is 
differentially spliced to produce five mRNAs: 
13 S, 12 S, 11 S, 10 S and 9 S [4,5]. The 13 S and 
12 S messengers encode polypeptides of 289 and 
243 amino acids, respectively, they differ one from 
the other only by an interna addition of 46 amino 
acids to the larger protein [l-3]. Both 13 S and 
12 S products have been reported to be important 
in: transcription activation of several cellular genes 
transcribed by RNA polymerase II or III; inhibi- 
tion of the expression of certain viral and cellular 
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genes; and transformation and immortalization of 
primary cells [ l-3,6]. 
Several enhancer elements have been described 
in the 5 ‘-ElA control regions of only the related 
serotypes 2 and 5 of subgroup C [7-91. Analysis of 
DNA sequences reveals that these enhancer 
elements are partially conserved in the Ad3 and 
Ad12 sequences upstream to ElA cap site but their 
organization is different (fig. 1). 
The aim of the present study has been to com- 
pare the upstream sequences of ElA cap site of 
Ad2, Ad3 and Ad12 fused to the cat gene and con- 
firm the hypothesis that different nuclear factors 
recognize each ElA promoter. 
2. MATERIALS AND METHODS 
2.1. Cells 
HeLa cells were grown as monolayers in Dulbecco’s medium 
(GIBCO) containing 5% newborn calf serum. 
2.2. HeLa cells transfection and CAT assay 
All transfections were carried out by using the calcium phos- 
phate coprecipitation technique [lo, 1 I]. The CAT assay was 
described previously [ 10,ll). 
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2.3. Plasmids Table 1 
pKH47 is a pBR322-derivate plasmid and it was supplied by 
Bethesda Research Laboratories. The pVM214, p2ElAcat and 
p3ElAcat were described previously [lO,ll]. The hybrid plas- 
mids: Ad2/Ad3 (-498 to - 45/ -46 to + 30 = pVM261), 
Ad2/Ad12 (- 498 to - 45/ - 45 to + 49 = pVM291), Ad3/Ad2 
(-510to -46/-45to +40=pVM315),Ad12/Ad2(-445to 
- 45/ - 45 to + 40 = pVM1210) were constructed using a PM1 
site which conserved 13 nucleotides (nt) upstream from the 
TATA box of ElA promoters. The nucleotide sequence (- 498 
to - 306) containing the enhancer ‘A’ [7] was deleted (pVM268) 
from p2ElAcat. The plasmid pVM293, without the first se- 
quence of enhancer ‘B’ [S], was obtained after eliminating the 
sequence between the Accl (- 306) and Ball (-229) from 
p2ElAcat. The pVM295 was obtained by deletion of the frag- 
ment extending between Sal1 (651) and Ndel (2387) restriction 
sites from p2ElAcat (pKH47 sequence); this fragment contain- 
ed a silencer sequence [12]. The pVM296 and pVM297 were 
constructed by insertion of an Xbal linker or a fragment of 
50 nt, respectively, in the Ball site present at - 229 of pVM295 
(fig.1). The pl2ElAcat contained the fragment O-494 nt from 
the pAdl2ElA. upstream from the encoding sequence for the 
cat gene. 
CAT activity in HeLa cells transfected with plasmids containing 
the cat gene under the control of EIA promoter of Ad2, Ad3 
or Ad12 
Plasmids CAT activity 
+ pKH47 + pVM214 b/a 
p2E 1 Acat 1 .ooa 2.26b 2.26 
p3ElAcat 0.47 2.26 4.80 
pl2ElAcat 0.84 2.00 2.30 
pVM261 0.47 2.25 4.78 
pVM29 1 0.95 2.10 2.21 
pVM315 0.94 2.35 2.50 
pVM1210 0.82 1.39 1.70 
pVM268 0.44 0.96 2.18 
pVM293 0.71 2.13 3.00 
pVM295 23.30 46.50 1.99 
pVM296 6.30 12.10 1.92 
pVM297 3.50 9.10 2.60 
CAT activity was assayed as previously described [lO,ll]. The 
relative CAT activities are expressed in arbitrary units; CAT ac- 
tivity: 1.00 corresponds to 1700 cpm [‘4C]Ac-Cm/min per I@ 
cells at 37°C. All values are averages from three separate ex- 
periments 
3. RESULTS 
To test the role of upstream sequences of ElA 
promoters, we inserted the 5 ‘-control regions of 
the ElA early gene of Ad2, Ad3 and Ad12 up- 
stream to the cat gene. The cat gene was reported 
as the best to study the complex regulation 
mechanism of the adenoviral gene in the absence 
of other viral gene products. Hybrid ElA pro- 
moters were constructed between Ad2 and Ad3, 
and Ad2 and Ad12. The enhancer sequences A [7] 
or B [S] were deleted from p2ElAcat. These plas- 
mids were introduced into HeLa cells and the ac- 
tivity of each promoter was readily assayed by 
measuring the extent of conversion of chloram- 
phenicol to its acetylated forms. 
stimulated the native or modified ElA promoters 
of Ad2, Ad3 and Ad12 (table 1). 
4. DISCUSSION 
The CAT activity appeared at low-level in HeLa 
cells transfected with the plasmids: p3ElAcat 
(native), pVM261 (hybrid), pVM268 and pVM293 
(deleted) (table 1). The same level of activity was 
observed for HeLa cells transfected with the plas- 
mids: p2ElAcat, pVM291, pVM315, pl2ElAcat 
and pVM1210 (table 1). A high level of CAT ac- 
tivity was observed when plasmids pVM295, 
pVM296 and pVM297 (table 1) without a silencer 
sequence were transfected, however, that activity 
decreased when the distance between two se- 
quences of enhancer B [8] increased (pVM296, 
pVM297). The Ad2 ElA gene products (pVM214) 
The organization of ElA non-coding sequences 
of Ad2, Ad3 and Ad12 is very different (fig.1). 
The distance between two sequences of enhancer B 
[8] is distinct among Ad2 (88 nt), Ad3 (97 nt) and 
Ad12 (119 nt). The enhancer A sequence [7] is in- 
cluded between two sequences of enhancer B [8] in 
Ad12 but not in Ad2 and Ad3 (fig.1). This 
organization, although different, is not important 
for the activity of ElA promoters, because the 
CAT activity of hybrid plasmids: pVM291, 
pVM315 and pVM1210 is similar to p2ElAcat and 
pl2ElAcat, and higher than pVM261 and 
p3ElAcat (table 1). 
Both enhancer elements described A and B [7,8] 
are required for full activity of the Ad2 ElA pro- 
moter (pVM268, pVM293) and the distance be- 
tween two sequences of enhancer B [8] is very 
important to the promoter activity (pVM295, 
pVM296, pVM297) (table 1). 
Two sequences recognized by the E2F cellular 
factor [13] are present between two sequences of 
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Fig.]. Organization of 5’-non-coding region ElA of adenovirus serotypes 2, 3 and 12. The enhancers A [7] and B [8], the sequences 
recognise for cellular factors E2F [13] and E4F1 [15], and ITR, inverted terminal repeat, are represented using the corresponding sym- 
bols. B, Ball; P, PvuII; T, TATA box. 
enhancer B [8] in Ad2 ElA (fig.1). The E2F binds recognized by this factor are absent in Ad12 ElA 
to the ElA enhancer as well as to the E2A-early (fig.l). The binding site for E4Fl cellular factor 
promoter, but does not interact with regulatory se- [15] is localized between the two sequences of 
quences of any other ElA-inducible genes (EIB, enhancer B [8] in Ad2 ElA (fig.1). The binding 
E3, E4 and 70 kDa hsp) [13]. The activation of the sites for this factor are localized upstream E2A, E3 
E2F factor probably results in a large stimulation and E4 cap site of Ad5 (Ad2) [15]. However, this 
of E2A transcription and a smaller stimulation of sequence is absent in Ad3 and Ad1 2 ElA pro- 
ElA transcription. It is likely that other proteins moters. The Ad2 ElA gene products can stimulate 
are important for stimulation of other promoters the cellular factor(sj that recognize(s) these dif- 
[ 141. One of two sequences recognized by the E2F ferent promoter organizations. The cellular factor 
factor is present between the sequences of present in non-infected HeLa cells [16] recognize 
enhancer B [8] in Ad3 and both sequences the ‘consensus’ core of Ad2 enhancer A [7], but 
235 
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this consensus varies between Ad2/Ad3, Ad2/ 
Ad12 and Ad3/Ad12 (fig.l). 
Why is the different organization of undamaged 
El A 5 ‘-non-coding sequences not essential for the 
full activity of promoters which control the ElA 
gene expression? 
It is possible that the different cellular factors 
recognize each ElA organization. The undamaged 
upstream sequences are probably required to form 
a transcriptional initiation stable complex and the 
TATA box is the critical sequence of this forma- 
tion [14,17,18]. 
The isolation of those cellular factors and the 
study of their competition in the different ElA 
regulatory sequences will be required for a better 
understanding of the still obscure process leading 
to the formation of the transcriptional complex. 
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